$DVLP is our new 1-cent cannabis play w/ +800pct in revenue...
=====================================
DVLP (Golden Developing Solutions Inc.)
Alert Price: $0.0168
Website | Recent News
=======================
Members,
We hope you enjoyed the long weekend, and took time for some much needed rest.
We've used our time wisely, and scanned the market for the next monster breakout trade.
One company that caught our attention was DVLP (Golden Developing Solutions Inc.).
Trading at just over a penny per share, this emerging leader in the Cannabis, Hemp, and CBD marketplace has more upside than most companies operating in the sector.
DVLP recently announced that, along with its recent acquisition, Infusionz, LLC (“CBD Infusionz”), that the two business entities have combined to achieve a record $590,488 in monthly revenues during March 2019, representing a massive 800% jump in combined performance on a year-over-year basis when compared to March 2018!
We did the quick math, and if DVLP were to continue this monthly revenue trend, annual revenues would equate to over 7M!
We can't think of any companies generating over 7M per year that are trading at just around 1-cent per share, which leads us to believe that DVLP is one of the most undervalued companies in the cannabis space.
This could be your perfect entry point for DVLP.
DVLP has a history of experiencing significant volatility.
In March DVLP traded as low as 0.0143, subsequently rallying to a high of 0.0269, an upside of more than 88% in just a few weeks.
Last week, we watched shares of DVLP run over +32% from $0.0177 to $0.0235.
Since this massive rally DVLP has consolidated back to its Thursday close of 0.0168.
DVLP appears to have found support here, and we believe that the next rally upwards to 2-cents, and beyond is about to take place!
That being said,we ask that you start your research now, and consider building a position in DVLP tomorrow morning at 9:30AM EST!
About Golden Developing Solutions, Inc.
Golden Developing Solutions (DVLP) is developing an online retail business for cannabidiol (CBD), hemp oil and health/wellness-related products. The Company is also developing a high-capacity, high-quality CBD extraction and production facility. In addition, through the website of its joint venture partner, Pura Vida Vitamins (PuraVidaVitamins.com), as well as through wholesale and distribution channels, the Company offers a broad range of high-quality, price-competitive products, including traditional vitamins, supplements, and CBD-based tinctures, vapes and soft gels, among other products. Merchandise also includes hemp and CBD-related products and additional products focusing on health and lifestyle.
Golden Developing Solutions is a development-stage company providing business services and/or products supporting the cannabis industry, in which company intends to make acquisitions in the near future. Currently, 29 states and the District of Columbia have passed laws permitting their citizens to use cannabis for medical and/or recreational purposes. Cannabis has shown encouraging signs as a treatment for various medical conditions and has become increasingly more acceptable to the public and society.
DVLP experienced a remarkable 2018, as the company noted in this announcement:
“Golden Developing Solutions Announces Nationwide Expansion of 'Where's Weed' Following Record Breaking $18 Million in Transactions”
A little about this platform:
“Since 2011, Where’s Weed has been dedicated to helping medical and recreational consumers find dispensaries, delivery services, strains, and deals in their local cannabis community.”
“Additionally, the platform helps cannabis companies connect with consumers and more efficiently manage and market their business in the digital space.”
Furthermore, the company announced:
“Golden Developing Solutions Announces 149% Q4 Rev Growth in “Where’s Weed” Division, Sees Accelerating Platform Growth in Q1 and 2019”
DVLP Acquires CBD Infusionz
DVLP secured powerful traction in the cannabis space as a service provider with their popular Where’s Weed app and portal. And, recently, they expanded this market coverage footprint by moving into the CBD space full force with their Where’s CBD portal, which is beginning to take root as a powerful resource.
That sets the stage for what they feel could be a true gamechanger in the quarters ahead, in terms of synergies and overall augmentation of their core growth proposition: their recent acquisition of Infusionz, LLC (“CBD Infusionz”), a premium manufacturer of high quality CBD products.
Why do they believe this acquisition is such an important move?
First off, it will immediately augment their topline growth data, which is a core factor for institutional investors in search of strong growth potential. They can now offer a better argument given the strong revenues they assume as we onboard CBD Infusionz. For example, if they backdate our analysis, the combined entity would have had total sales of more than 500K in February alone.
In addition, following this acquisition, they have a fully developed retail, wholesale, distribution, and white labeling operation in the CBD space to augment their Where’s CBD services offering.
In fact, with CBD Infusionz operationally integrated, they will now have on offer more than 150 product SKU’s, including vegan products, pet products, pre-rolls, concentrates, creams and lotions, muscle freeze, massage oil, and premium products with existing brand traction such as the Saucy Boss Concentrate line and the Terpy J Pre-roll line.
In short, they emerge from this deal with a powerful value proposition for new investment capital. Their equity is now trading at just 2X our 2019 projected sales, which represents a run rate of $6 million on an annualized basis at current levels. That run rate is also a fixed point on a steep growth curve that shows evidence of a 4-6 month doubling rate at present.
And, perhaps most importantly, they are tethered to arguably the two most robust growth markets on the planet right now in cannabis and CBD. Following this acquisition, they are now more focused on CBD than we have been in the past because the growth curve is even more robust in CBD than it is in cannabis, given the lack of legal barriers to mainstream adoption by consumers in North America. Recent updated forecasts now anticipate a twenty-fold ramp in total sales volume over the next 36 months in the CBD marketplace to over $20 billion, according to several prominent forecasts.
In other words, we believe, with their recent acquisition of CBD Infusionz, they have assembled the pieces of a very strong shareholder value proposition over coming quarters and years.
They will continue to act according to the principles that have taken them this far. They have a number of exciting plans in the works, and they will do their best to keep you updated as they move forward.
Recent Developments
Golden Developing Solutions Reports Record 800% Jump in Combined-Entity Revenues for March 2019
DENVER, April 15, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Golden Developing Solutions, Inc. (DVLP) (“DVLP” or the “Company”), an emerging leader in the Cannabis, Hemp, and CBD marketplace, is excited to announce, along with its recent acquisition, Infusionz, LLC (“CBD Infusionz”), that the two business entities have combined to achieve a record $590,488 in monthly revenues during March 2019, representing a massive 800% jump in combined performance on a year-over-year basis when compared to March 2018.
“We are seeing tremendous validation on a strategic level,” commented DVLP CEO Stavros Triant. “The move to expand our exposure to the CBD space was very well-timed, and is already beginning to pay off. The numbers for March bear that out unmistakably.”
Management notes that this data demonstrate a dramatic growth curve on both an annual and sequential monthly basis, with the comparative March monthly year-over-year and the sequential monthly data showing appreciable growth. As noted above, the year-over-year monthly comparable revenue data increased by 800% while the sequential monthly data showed an increase of nearly 18%, which represents a follow-on annualized growth rate of 630% over the coming 12 months.
According to recent macro analysis of the CBD space, that level of growth is not particularly remarkable given the market context. Analysts have begun to project similar exponential growth in the CBD space over the next 36 months following the signing of the 2018 Farm Bill, which opened the door to a much easier path of mainstream expansion in hemp-based CBD sales in the United States.
“As we integrate CBD Infusionz, we will be dramatically increasing our operational potential,” continued Mr. Triant. “Where’s Weed and Where’s CBD have provided powerful growth catalysts on the services side. But the addition of a true leadership asset on the CBD product side sharply amplifies our growth proposition at an ideal time from an industry standpoint.”
Market Outlook:
Growth of “consumer spending on legal cannabis” is expected to “accelerate in 2019, jumping 38% to $16.9 billion."
This number is expected “to reach $31.3 billion in 2022”.
But the US could provide the sector with an even bigger opportunity.
According to Business Insider, “recreational marijuana is now legal in 10 states; medical marijuana is legal in 33.”
But here is where this gets exciting for the sector, and why there has been so much enthusiasm recently…
According to MarketWatch, members of the US Congress plan to pass a Marijuana Banking Bill in 2019.
This could be another positive catalyst for the sector in the US as regulations further ease.
The movement is gaining traction too…
The “New Marijuana Banking Bill In Congress Has 108 Cosponsors”.
In fact, in a huge development, two weeks ago it was reported by Forbes: “Marijuana Banking Bill Approved By Congressional Committee”
This could be another massively positive catalyst for companies in this sector in the world’s largest economy.
Technical Analysis
DVLP has historic volatility, and has reversed hard off these levels time and time again.
It is also trading just slightly above its 52-week low, which leads us to believe that its upside potential far outweighs its downside risk.
In fact, a run back to its 52-week high of $0.14 from today's alert price would net traders over +733% in pure profit!
The Bottom Line
With growing revenues, and a solid plan for growth, DVLP appears to be grossly undervalued at its current share price.
Those who grab up shares at these levels could be handsomely rewarded in the immediate future.
That being said, we ask that all members start their research on DVLP immediately, and consider building a position tomorrow morning at 9:30AM EST
(*Remember to use a Stop-Loss Order or basic Limit Order to protect your gains, as well as limit possible losses.)
Best Regards,
The PennyStock101 Team
Don't Miss Our Next Huge Winner...
Text 'PS101' to '67076'
to have our Trade Alerts
Delivered Direct
to your Cell Phone.
(There is no charge.
Msg&data rates may apply.)
DISCLAIMER
This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by both MJ Capital, LLC and PennyStockLocks, LLC. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” refers to MJ Capital, LLC and PennyStockLocks, LLC. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website.
We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. MJ Capital does NOT own any shares of the companies mentioned herewithin, nor intends to buy any in the future.
MJ Capital’s business model is to receive financial compensation to promote public companies. We have been compensated ten thousand dollars by One 22 Media LLC to conduct investor relations advertising and marketing for DVLP. Any compensation is a major conflict of interest in our ability to be unbiased. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors.
We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, MJ Capital often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice.
DVLP (Golden Developing Solutions Inc.)
Alert Price: $0.0168
Website | Recent News
=======================
Members,
We hope you enjoyed the long weekend, and took time for some much needed rest.
We've used our time wisely, and scanned the market for the next monster breakout trade.
One company that caught our attention was DVLP (Golden Developing Solutions Inc.).
Trading at just over a penny per share, this emerging leader in the Cannabis, Hemp, and CBD marketplace has more upside than most companies operating in the sector.
DVLP recently announced that, along with its recent acquisition, Infusionz, LLC (“CBD Infusionz”), that the two business entities have combined to achieve a record $590,488 in monthly revenues during March 2019, representing a massive 800% jump in combined performance on a year-over-year basis when compared to March 2018!
We did the quick math, and if DVLP were to continue this monthly revenue trend, annual revenues would equate to over 7M!
We can't think of any companies generating over 7M per year that are trading at just around 1-cent per share, which leads us to believe that DVLP is one of the most undervalued companies in the cannabis space.
This could be your perfect entry point for DVLP.
DVLP has a history of experiencing significant volatility.
In March DVLP traded as low as 0.0143, subsequently rallying to a high of 0.0269, an upside of more than 88% in just a few weeks.
Last week, we watched shares of DVLP run over +32% from $0.0177 to $0.0235.
Since this massive rally DVLP has consolidated back to its Thursday close of 0.0168.
DVLP appears to have found support here, and we believe that the next rally upwards to 2-cents, and beyond is about to take place!
That being said,we ask that you start your research now, and consider building a position in DVLP tomorrow morning at 9:30AM EST!
About Golden Developing Solutions, Inc.
Golden Developing Solutions (DVLP) is developing an online retail business for cannabidiol (CBD), hemp oil and health/wellness-related products. The Company is also developing a high-capacity, high-quality CBD extraction and production facility. In addition, through the website of its joint venture partner, Pura Vida Vitamins (PuraVidaVitamins.com), as well as through wholesale and distribution channels, the Company offers a broad range of high-quality, price-competitive products, including traditional vitamins, supplements, and CBD-based tinctures, vapes and soft gels, among other products. Merchandise also includes hemp and CBD-related products and additional products focusing on health and lifestyle.
Golden Developing Solutions is a development-stage company providing business services and/or products supporting the cannabis industry, in which company intends to make acquisitions in the near future. Currently, 29 states and the District of Columbia have passed laws permitting their citizens to use cannabis for medical and/or recreational purposes. Cannabis has shown encouraging signs as a treatment for various medical conditions and has become increasingly more acceptable to the public and society.
DVLP experienced a remarkable 2018, as the company noted in this announcement:
“Golden Developing Solutions Announces Nationwide Expansion of 'Where's Weed' Following Record Breaking $18 Million in Transactions”
A little about this platform:
“Since 2011, Where’s Weed has been dedicated to helping medical and recreational consumers find dispensaries, delivery services, strains, and deals in their local cannabis community.”
“Additionally, the platform helps cannabis companies connect with consumers and more efficiently manage and market their business in the digital space.”
Furthermore, the company announced:
“Golden Developing Solutions Announces 149% Q4 Rev Growth in “Where’s Weed” Division, Sees Accelerating Platform Growth in Q1 and 2019”
DVLP Acquires CBD Infusionz
DVLP secured powerful traction in the cannabis space as a service provider with their popular Where’s Weed app and portal. And, recently, they expanded this market coverage footprint by moving into the CBD space full force with their Where’s CBD portal, which is beginning to take root as a powerful resource.
That sets the stage for what they feel could be a true gamechanger in the quarters ahead, in terms of synergies and overall augmentation of their core growth proposition: their recent acquisition of Infusionz, LLC (“CBD Infusionz”), a premium manufacturer of high quality CBD products.
Why do they believe this acquisition is such an important move?
First off, it will immediately augment their topline growth data, which is a core factor for institutional investors in search of strong growth potential. They can now offer a better argument given the strong revenues they assume as we onboard CBD Infusionz. For example, if they backdate our analysis, the combined entity would have had total sales of more than 500K in February alone.
In addition, following this acquisition, they have a fully developed retail, wholesale, distribution, and white labeling operation in the CBD space to augment their Where’s CBD services offering.
In fact, with CBD Infusionz operationally integrated, they will now have on offer more than 150 product SKU’s, including vegan products, pet products, pre-rolls, concentrates, creams and lotions, muscle freeze, massage oil, and premium products with existing brand traction such as the Saucy Boss Concentrate line and the Terpy J Pre-roll line.
In short, they emerge from this deal with a powerful value proposition for new investment capital. Their equity is now trading at just 2X our 2019 projected sales, which represents a run rate of $6 million on an annualized basis at current levels. That run rate is also a fixed point on a steep growth curve that shows evidence of a 4-6 month doubling rate at present.
And, perhaps most importantly, they are tethered to arguably the two most robust growth markets on the planet right now in cannabis and CBD. Following this acquisition, they are now more focused on CBD than we have been in the past because the growth curve is even more robust in CBD than it is in cannabis, given the lack of legal barriers to mainstream adoption by consumers in North America. Recent updated forecasts now anticipate a twenty-fold ramp in total sales volume over the next 36 months in the CBD marketplace to over $20 billion, according to several prominent forecasts.
In other words, we believe, with their recent acquisition of CBD Infusionz, they have assembled the pieces of a very strong shareholder value proposition over coming quarters and years.
They will continue to act according to the principles that have taken them this far. They have a number of exciting plans in the works, and they will do their best to keep you updated as they move forward.
Recent Developments
Golden Developing Solutions Reports Record 800% Jump in Combined-Entity Revenues for March 2019
DENVER, April 15, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Golden Developing Solutions, Inc. (DVLP) (“DVLP” or the “Company”), an emerging leader in the Cannabis, Hemp, and CBD marketplace, is excited to announce, along with its recent acquisition, Infusionz, LLC (“CBD Infusionz”), that the two business entities have combined to achieve a record $590,488 in monthly revenues during March 2019, representing a massive 800% jump in combined performance on a year-over-year basis when compared to March 2018.
“We are seeing tremendous validation on a strategic level,” commented DVLP CEO Stavros Triant. “The move to expand our exposure to the CBD space was very well-timed, and is already beginning to pay off. The numbers for March bear that out unmistakably.”
Management notes that this data demonstrate a dramatic growth curve on both an annual and sequential monthly basis, with the comparative March monthly year-over-year and the sequential monthly data showing appreciable growth. As noted above, the year-over-year monthly comparable revenue data increased by 800% while the sequential monthly data showed an increase of nearly 18%, which represents a follow-on annualized growth rate of 630% over the coming 12 months.
According to recent macro analysis of the CBD space, that level of growth is not particularly remarkable given the market context. Analysts have begun to project similar exponential growth in the CBD space over the next 36 months following the signing of the 2018 Farm Bill, which opened the door to a much easier path of mainstream expansion in hemp-based CBD sales in the United States.
“As we integrate CBD Infusionz, we will be dramatically increasing our operational potential,” continued Mr. Triant. “Where’s Weed and Where’s CBD have provided powerful growth catalysts on the services side. But the addition of a true leadership asset on the CBD product side sharply amplifies our growth proposition at an ideal time from an industry standpoint.”
Market Outlook:
Growth of “consumer spending on legal cannabis” is expected to “accelerate in 2019, jumping 38% to $16.9 billion."
This number is expected “to reach $31.3 billion in 2022”.
But the US could provide the sector with an even bigger opportunity.
According to Business Insider, “recreational marijuana is now legal in 10 states; medical marijuana is legal in 33.”
But here is where this gets exciting for the sector, and why there has been so much enthusiasm recently…
According to MarketWatch, members of the US Congress plan to pass a Marijuana Banking Bill in 2019.
This could be another positive catalyst for the sector in the US as regulations further ease.
The movement is gaining traction too…
The “New Marijuana Banking Bill In Congress Has 108 Cosponsors”.
In fact, in a huge development, two weeks ago it was reported by Forbes: “Marijuana Banking Bill Approved By Congressional Committee”
This could be another massively positive catalyst for companies in this sector in the world’s largest economy.
Technical Analysis
DVLP has historic volatility, and has reversed hard off these levels time and time again.
It is also trading just slightly above its 52-week low, which leads us to believe that its upside potential far outweighs its downside risk.
In fact, a run back to its 52-week high of $0.14 from today's alert price would net traders over +733% in pure profit!
The Bottom Line
With growing revenues, and a solid plan for growth, DVLP appears to be grossly undervalued at its current share price.
Those who grab up shares at these levels could be handsomely rewarded in the immediate future.
That being said, we ask that all members start their research on DVLP immediately, and consider building a position tomorrow morning at 9:30AM EST
(*Remember to use a Stop-Loss Order or basic Limit Order to protect your gains, as well as limit possible losses.)
Best Regards,
The PennyStock101 Team
Don't Miss Our Next Huge Winner...
Text 'PS101' to '67076'
to have our Trade Alerts
Delivered Direct
to your Cell Phone.
(There is no charge.
Msg&data rates may apply.)
DISCLAIMER
This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by both MJ Capital, LLC and PennyStockLocks, LLC. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” refers to MJ Capital, LLC and PennyStockLocks, LLC. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website.
We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. MJ Capital does NOT own any shares of the companies mentioned herewithin, nor intends to buy any in the future.
MJ Capital’s business model is to receive financial compensation to promote public companies. We have been compensated ten thousand dollars by One 22 Media LLC to conduct investor relations advertising and marketing for DVLP. Any compensation is a major conflict of interest in our ability to be unbiased. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors.
We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, MJ Capital often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice.
⭐⭐⭐ Sign Up for Free ⭐⭐⭐
1) Download our Mobile App >> link-to.app/dexwirenews
2) Join our Telegram >> t.me/DEXWireNews
3) Sign Up for Text Alerts >>
dexwirenews.com/TEXT
4) Follow @DEXWireNews on Social Media
1) Download our Mobile App >> link-to.app/dexwirenews
2) Join our Telegram >> t.me/DEXWireNews
3) Sign Up for Text Alerts >>
dexwirenews.com/TEXT
4) Follow @DEXWireNews on Social Media
Clause de non-responsabilité
Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.